Prevail Therapeutics Acquired by Lilly

Prevail Announces First Patient Dosed

Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001

Aspen Neuroscience Announces $70 Million Series A Financing

The Silverstein Foundation and Q-State Biosciences Launch Chamishi Therapeutics

NEW YORK and CAMBRIDGE, Mass., Sept 26, 2019 (GLOBE NEWSWIRE) – The Silverstein Foundation for Parkinson’s with GBA and Q-State Biosciences today announced the formation and launch of Chamishi Therapeutics, a drug discovery and development company focused on...

The Michael J. Fox Foundation and The Silverstein Foundation for Parkinson’s with GBA Grant Nearly $3 Million to Studies into Disease’s Most Common Known Genetic Contributor

NEW YORK (February 20, 2019) – The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Foundation for Parkinson’s with GBA announce nearly $3 million in grants to studies investigating glucocerebrosidase beta acid (GBA). Mutations in the...